Interactions Between lncRNA TUG1 and miR-9-5p Modulate the Resistance of Breast Cancer Cells to Doxorubicin by Regulating eIF5A2
OncoTargets and Therapy2020Vol. Volume 13, pp. 13159–13170
Citations Over TimeTop 14% of 2020 papers
Abstract
TUG1 modulates the susceptibility of BC cells to Dox by regulating the expression of eIF5A2 via interacting with miR-9. These results indicate that the lncRNA TUG1 may be a novel therapeutic target in breast cancer.
Related Papers
- → Intramyocardial Injection of siRNAs Can Efficiently Establish Myocardial Tissue-Specific Renalase Knockdown Mouse Model(2016)4 cited
- → 705. A Practical Approach to siRNA-Based Treatment Design Using Bioluminescent Imaging and Mathematical Modeling(2006)1 cited
- → siRNA-mediated knockdown of the Nav1.8 sodium channel(2005)
- Application of two types of RNA to develope DJ-1 knockdown cell model(2011)
- Double-mismatched siRNAs enhance selective gene silencing of a mutant ALS-causing allele(2008)